» Articles » PMID: 24081407

Screening for Metabolic Risk Among Patients with Severe Mental Illness and Diabetes: a National Comparison

Overview
Journal Psychiatr Serv
Specialty Psychiatry
Date 2013 Oct 2
PMID 24081407
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: People with severe mental illness have a higher risk of developing cardiovascular disease and die sooner than the general population. This study of a national sample of primary care patients in the United Kingdom compared screening for cardiometabolic risk factors among patients with severe mental illness and diabetes.

Methods: Screening for cardiovascular disease among 2,488,948 patients with diabetes (2010-2011) and 422,966 patients with severe mental illness (2011-2012) at 8,123 primary care practices was compared.

Results: The percentage of patients who received screening across four parameters (body mass index, blood pressure, blood glucose, and cholesterol) in the previous 15 months was higher among patients with diabetes than among those with severe mental illness (97.3% versus 74.7%, p<.001).

Conclusions: The proportion of patients in primary care who were given screening for cardiometabolic risk was much lower among those with severe mental illness than among those with diabetes.

Citing Articles

Status of primary and secondary mental healthcare of people with severe mental illness: an epidemiological study from the UK PARTNERS2 programme.

Reilly S, McCabe C, Marchevsky N, Green M, Davies L, Ives N BJPsych Open. 2021; 7(2):e53.

PMID: 33583478 PMC: 8058911. DOI: 10.1192/bjo.2021.10.


Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational study.

Mitchell A, Vancampfort D, Manu P, Correll C, Wampers M, van Winkel R PLoS One. 2019; 14(9):e0210674.

PMID: 31513598 PMC: 6742458. DOI: 10.1371/journal.pone.0210674.


Cardiovascular preventive care for patients with serious mental illness.

Ritchie S, Muldoon L Can Fam Physician. 2017; 63(11):e483-e487.

PMID: 29138173 PMC: 5685464.


Artesunate prevents rats from the clozapine-induced hepatic steatosis and elevation in plasma triglycerides.

Li Y, Su R, Xu S, Huang Q, Xu H Neuropsychiatr Dis Treat. 2017; 13:2477-2487.

PMID: 29026311 PMC: 5627760. DOI: 10.2147/NDT.S145069.


Cardiovascular disease treatment among patients with severe mental illness: a data linkage study between primary and secondary care.

Woodhead C, Ashworth M, Broadbent M, Callard F, Hotopf M, Schofield P Br J Gen Pract. 2016; 66(647):e374-81.

PMID: 27114210 PMC: 4871302. DOI: 10.3399/bjgp16X685189.